AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75F40120C00060TOXICOLOGIC PATHOLOGY ASSOCIATES INC
Overview
Award facts
- Net obligations
- $23.90M
- $23,901,717of $24.58M potential value
- Outlays (paid to date)
- $19.12M
- $19.12M paid of $23.90M obligated$19,120,164
- Period of performance
- Jul 14, 2020 to Sep 15, 2025
- Ended
- Modifications
- 20
- Latest action Dec 29, 2025
- Contract type
- Definitive contract
- PIID 75F40120C00060
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
ON-SITE PATHOLOGY SERVICES
Dates and value
- Award date
- Signed on Jul 14, 2020
- Potential end of performance
- Sep 14, 2025
- Current value
- $24,579,600Base and exercised options
- Potential value (if all options are exercised)
- $24,579,600
Obligations by fiscal year of action
- FY2026: -$218,910 (de-obligation)
- FY2025: $1,026,996
- FY2024: $4,828,602
- FY2023: $4,684,717
- FY2022: $4,848,584
- FY2021: $4,366,075
- FY2020: $4,365,653
Total across 7 fiscal years: $23,901,717
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 29, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationFREDERICK, MD
UEIPMMBWH3UHBV7
CAGE code30PB0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyTOXICOLOGIC PATHOLOGY ASSOCIATES INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugs; National center for toxicological research; Fda other activities (fda headquaters); Fda user fees (non general fund); Fda reimbursable program (federal sources)Program activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Jefferson, Arkansas 72079-0001
- Congressional district (place of performance)
- AR-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- Q515MEDICAL- PATHOLOGY (service)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Labor hoursZ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- FDA-SOL-128123(as reported)
- Solicitation date
- Apr 20, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction uses GFE/GFPY
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 14, 2020Base obligation at award: $3,782,653
- Latest action
- Dec 29, 2025 — CloseoutModification P00020; obligation change -$218,910; administrative: no change in scope or value
- Latest substantive action
- Jul 18, 2025 — Option exercisedModification P00019; obligation change +$836,042
- Latest funding action
- Jun 15, 2022 — Funding onlyModification P00009; obligation change +$186,000; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Option exercised8
- Funding only5
- Supplemental agreement (within scope)3
- Other administrative action3
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$218,910
- Latest action: change in base and all options
- -$218,910
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- Yes
- Walsh-Healey Act (materials and supplies)
- Yes
- Construction wage rates (Davis-Bacon)
- Yes
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 21
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2020/2020-0600-000
- 075-2021/2021-0600-000
- 075-2022/2022-0600-000
- 075-2023/2023-0600-000
- 075-2024/2024-0600-000
- 075-2025/2025-0600-000
Show all 7 accounts
- 075-X-0600-000
- Object classes
- 21.0: Travel and transportation of persons
- 25.4: Operation and maintenance of facilities
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression